Zhaoyang Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Top Venues

Thoracic cancer

Journal of pineal research

This page only lists publications with an associated author ORCID identifier.

Publications

Hongtao Duan, Zhaoyang Wang, Lili Cao, Yifang Zhu, Liping Tong, Xiao-Long Yan
A prospective single-center, single-arm, open-label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer. Thoracic cancer 15 (19) (2024)
Hongtao Duan, Zhaoyang Wang, Lili Cao, Yifang Zhu, Liping Tong, Xiao-Long Yan
A prospective single-center, single-arm, open-label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer. Thoracic cancer 15 (19) (2024)
Hongtao Duan, Zhaoyang Wang, Lili Cao, Yifang Zhu, Liping Tong, Xiao-Long Yan
A prospective single-center, single-arm, open-label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer. Thoracic cancer 15 (19) (2024)
Hongtao Duan, Zhaoyang Wang, Lili Cao, Yifang Zhu, Liping Tong, Xiao-Long Yan
A prospective single-center, single-arm, open-label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer. Thoracic cancer 15 (19) (2024)
Hongtao Duan, Zhaoyang Wang, Lili Cao, Yifang Zhu, Liping Tong, Xiao-Long Yan
A prospective single-center, single-arm, open-label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer. Thoracic cancer (2024)
Zhaoyang Wang, Zhaoyang Wang, Changjian Shao, Guofang Lu, Mei Xie, Jian Wang, Hongtao Duan, Xiaofei Li, Wanpeng Yu, Weixun Duan, Xiao-Long Yan
Melatonin may suppress lung adenocarcinoma progression via regulation of the circular noncoding RNA hsa_circ_0017109/miR-135b-3p/TOX3 axis. Journal of pineal research 73 (2) (2022)